Showing results (61-70 of 128) with videos related to
Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccineGilles Bioley, Philippe Guillaume, Immanuel Luescher, et al.Plos Computational Biology|August 24, 2017
Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificityMichal Bassani-Sternberg, Chloé Chong, Philippe Guillaume, et al.Frontiers in Immunology|August 29, 2022
CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinityPetra Baumgaertner, Julien Schmidt, Carla-Marisa Costa-Nunes, et al.Journal for Immunotherapy of Cancer|January 11, 2025
Preclinical model for evaluating human TCRs against chimeric syngeneic tumorsAikaterini Semilietof, Evangelos Stefanidis, Elise Gray-Gaillard, et al.Journal of Immunological Methods|March 7, 2006
Dextramers: new generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cellsPascal Batard, Daniel A Peterson, Estelle Devêvre, et al.The Journal of Experimental Medicine|September 8, 2010
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patientsJulien Fourcade, Zhaojun Sun, Mourad Benallaoua, et al.Proceedings of the National Academy of Sciences of the United States of America|May 2, 2018
The C-terminal extension landscape of naturally presented HLA-I ligandsPhilippe Guillaume, Sarah Picaud, Petra Baumgaertner, et al.Blood|May 18, 2012
Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemiaJochen Greiner, Yoko Ono, Susanne Hofmann, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTLVerena Rubio-Godoy, Valérie Dutoit, Yingdong Zhao, et al.Seminars in Cancer Biology|March 6, 2004
Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cellsDaniel E Speiser, Mikaël J Pittet, Donata Rimoldi, et al.Pageof 13